rs10773771 — PIWIL1 PIWIL1 3'UTR C>T

PIWIL1 rs10773771 — A Protective 3'UTR Variant in the Ovarian Cancer Genome Sentinel

PIWIL1 (also known as HIWI) is one of four human PIWI proteins, a conserved family of RNA-guided genome guardians that silence transposable elements in germ cells. These mobile genetic elements¹¹ mobile genetic elements
transposons and endogenous retroviruses that can copy themselves and re-insert elsewhere in the genome, causing mutations and genomic instability are particularly threatening in the ovary, where follicular cells and their oocytes must preserve genomic integrity across a woman's entire reproductive lifespan. PIWIL1 binds piRNAs — a class of small non-coding RNAs derived from transposon sequences — and uses them as guides to recognise and silence their source elements before they can replicate or cause double-strand breaks.

The rs10773771 C>T variant lies in the 3' untranslated region (3'UTR) of the PIWIL1 transcript. The 3'UTR is a regulatory hub where microRNAs bind to control mRNA stability and translation; a single nucleotide change here can substantially alter how tightly a given miRNA represses the gene. The T allele creates a structural shift in the local mRNA folding and modifies miRNA binding affinity to the 3'UTR, with measurable eQTL effects on PIWIL1 expression in multiple tissues.

The Mechanism

Reporter gene and bioinformatics analyses by Liu et al. 2013²² Liu et al. 2013
Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma. Mol Carcinog 2014 demonstrated that rs10773771 changes the binding ability of miRNAs to the 3'UTR of PIWIL1 in cell-based assays. The T allele reduces repression of PIWIL1 by one or more targeting miRNAs, potentially allowing higher PIWIL1 expression. Consistent with this, GTEx eQTL data shows the CC genotype is significantly associated with altered PIWIL1 transcript levels in skin (P = 1.5×10⁻¹⁰) and thyroid tissue (P = 4.9×10⁻⁶), with the T allele correlating with expression patterns distinct from C/C homozygotes. Computational modelling confirms that rs10773771 alters the mRNA secondary structure at the 3'UTR, modifying the accessibility of regulatory motifs.

In the ovary, PIWIL1 is expressed in follicular cells and is thought to protect the genomic stability of both oocytes and the somatic cells surrounding them. Higher or more appropriately regulated PIWIL1 activity, as the T allele may support, could translate into more effective transposon silencing and reduced mutagenic stress in these cells — a plausible mechanism linking the T allele to lower epithelial ovarian cancer (EOC) risk.

The Evidence

The primary clinical association comes from a three-center case-control study by Liu et al. 2023³³ three-center case-control study by Liu et al. 2023
Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese women. BMC Cancer 2023 examining 288 EOC cases and 361 healthy controls from southern China. Using TaqMan genotyping and multinomial logistic regression, the study found the rs10773771 CT/TT genotypes were associated with decreased EOC susceptibility. The protective effect was most pronounced in subgroups including women aged 53 years and older, those with advanced clinical stage, high pathological grade tumours, and those with specific biomarker expression profiles. Haplotype analysis confirmed that carriers of the GTG haplotype (incorporating the T allele at rs10773771) showed significantly decreased susceptibility relative to the reference GCG haplotype.

Supporting functional evidence from the same research group and others shows that this 3'UTR variant consistently modulates PIWIL1 post-transcriptional regulation across multiple cancer contexts, including hepatocellular carcinoma, stroke, and paediatric leukaemia — suggesting the variant's functional impact on PIWIL1 expression is real, even if the downstream phenotypic consequences vary by tissue and disease context.

Important limitations: The EOC association comes from a single case-control study of 649 participants from southern China. Replication in independent cohorts, particularly in non-East-Asian populations where T allele frequencies differ (East Asian ~63%, European ~60%, African ~31%), has not been published. The evidence level is therefore emerging and the association should be interpreted cautiously until replicated.

Practical Actions

For women carrying two C alleles (CC genotype), who may have relatively lower PIWIL1 3'UTR regulatory efficiency, the primary consideration is awareness of the modest EOC susceptibility signal and whether standard gynaecological surveillance is in place. This does not warrant intensive screening beyond age-appropriate guidelines — the evidence is from one study in a specific population and the absolute risk elevation is uncertain. CT and TT carriers appear to have typical-to-reduced EOC susceptibility from this variant.

Because PIWIL1 is a transposon-silencing genome guardian, oxidative and genotoxic stressors that generate DNA double-strand breaks (tobacco smoke, ionising radiation, certain endocrine-disrupting chemicals) may compound the impact of any reduction in PIWIL1 effectiveness. Minimising genotoxic exposures is prudent for CC carriers.

Interactions

rs10773771 is independent of rs28416520, a regulatory promoter variant in the same PIWIL1 gene associated with earlier age at natural menopause via a recessive mechanism. These two variants affect PIWIL1 through distinct molecular mechanisms — rs28416520 alters promoter methylation and transcription initiation, while rs10773771 modifies 3'UTR miRNA binding and post-transcriptional regulation. Women carrying both CC at rs10773771 and AA at rs28416520 may have additive reduction in PIWIL1 activity through two independent mechanisms, though no published study has examined this combination.

rs10848087 (PIWIL1 G>A) is a companion SNP from the same 2023 EOC study that increases EOC susceptibility; it and rs10773771 may tag partially independent functional elements within the PIWIL1 locus.